Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis

被引:16
|
作者
Tang, Yingying [1 ,2 ]
Zhang, Tianhong [1 ,2 ]
Edelman, Bradley [3 ]
Zeng, Botao [2 ]
Zhao, Shanshan [1 ]
Li, Chunyan [1 ]
Zhuo, Kaiming [2 ]
Qian, Zhenying [1 ]
Li, Hui [1 ]
Guo, Qian [1 ]
Cui, Huiru [1 ]
Zhu, Yikang [1 ]
Jiang, Lijuan [1 ]
Li, Chunbo [1 ,2 ]
Yu, Dehua [4 ]
Wang, Jijun [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept EEG & Imaging, Shanghai 200030, Peoples R China
[3] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA
[4] Tongji Univ, Sch Med, YangPu Hosp, Dept Psychiat, Shanghai 200090, Peoples R China
基金
中国国家自然科学基金;
关键词
Ultra-high risk of psychosis; Schizophrenia; Cortical inhibition; Short-interval cortical inhibition; Cortical silent period; TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; NEGATIVE SYNDROME SCALE; HIGH-CLINICAL-RISK; 1ST-EPISODE SCHIZOPHRENIA; INHIBITORY DEFICITS; PRODROMAL SYMPTOMS; BRAIN-STIMULATION; NEURAL SYNCHRONY; IN-VIVO;
D O I
10.1016/j.schres.2014.10.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Deficits in gamma-aminobutyric acid (GABA) inhibitory neurotransmission have been associated with pathophysiological mechanisms underlying schizophrenia. However, little is known about whether these deficits occur before or after the onset of psychosis. Method: We recruited 16 drug-naive subjects at ultra-high risk of psychosis (UHR), 17 schizophrenia patients and 28 healthy controls. Cortical inhibition was determined using transcranial magnetic stimulation (TMS) over the left primary motor cortex. TMS markers such as short-interval cortical inhibition (SICI), cortical silent period (CSP) and intracortical facilitation (ICF) were obtained from each subject. While SICI can reflect GABA type A (GABA(A)) mediated inhibition, CSP is thought to indicate GABA type B (GABA(B)) mediated inhibitory circuits. Results: As compared with healthy controls, UHR subjects showed a prolonged CSP with no change in SICI, whereas schizophrenia patients demonstrated both a prolonged CSP and a reduced SICI. No group differences were found for ICF. CSP in schizophrenia patients also had a positive correlation with positive symptom score of the positive and negative symptom scale (PANSS). Conclusions: Cortical inhibitory deficits among UHR subjects were relatively limited compared to those among schizophrenia patients. Alterations might occur in some subgroup of GABA-mediated neurotransmitter systems before the onset of psychosis, while alterations in both GABA(A) and GABA(B) networks might contribute to full blown psychosis. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 50 条
  • [1] Risperidone increases the cortical silent period in drug-naive patients with first-episode schizophrenia: A transcranial magnetic stimulation study
    Ustohal, Libor
    Mayerova, Michaela
    Hublova, Veronika
    Kucerova, Hana Prikrylova
    Ceskova, Eva
    Kasparek, Tomas
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (04) : 500 - 504
  • [2] Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
    Modinos, Gemma
    Simsek, Fatma
    Horder, Jamie
    Bossong, Matthijs
    Bonoldi, Ilaria
    Azis, Matilda
    Perez, Jesus
    Broome, Matthew
    Lythgoe, David J.
    Stone, James M.
    Howes, Oliver D.
    Murphy, Declan G.
    Grace, Anthony A.
    Allen, Paul
    McGuire, Philip
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (02): : 114 - 119
  • [3] Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis An Open-Label Study
    Liu, Chen-Chung
    Chien, Yi-Ling
    Hsieh, Ming H.
    Hwang, Tzung-Jeng
    Hwu, Hai-Gwo
    Liu, Chih-Min
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 18 - 23
  • [4] Plasmatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis
    Joaquim, Helena P. G.
    Costa, Alana C.
    Pereira, Cicero A. C.
    Talib, Leda L.
    Bilt, Martinus M., V
    Loch, Alexandre A.
    Gattaz, Wagner F.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2022, 55 (04) : 1079 - 1087
  • [5] Neural correlate of impulsivity in subjects at ultra-high risk for psychosis
    Lee, Tae Young
    Kim, Sung Nyun
    Jang, Joon Hwan
    Shim, Geumsook
    Jung, Wi Hoon
    Shin, Na Young
    Kwon, Jun Soo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 45 : 165 - 169
  • [6] Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study
    Byun, Min Soo
    Choi, Jung-Seok
    Yoo, So Young
    Kang, Do-Hyung
    Choi, Chi-Hoon
    Jang, Dong Pyo
    Jung, Wi Hoon
    Jung, Myung Hun
    Jang, Joon Hwan
    Lee, Jong-Min
    Kwon, Jun Soo
    PSYCHIATRY INVESTIGATION, 2009, 6 (04) : 264 - 271
  • [7] Neuropsychology of subjects with ultra-high risk (UHR) of psychosis: A critical analysis of the literature
    Mam-lam-Fook, C.
    Danset-Alexandre, C.
    Pedron, L.
    Amado, I.
    Gaillard, R.
    Krebs, M-O.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (03): : 241 - 253
  • [8] Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk
    Jang, Joon Hwan
    Shin, Na Young
    Shim, Geumsook
    Park, Hye Yoon
    Kim, Euitae
    Jang, Go-Eun
    Kwon, Soo Jin
    Hur, Ji-Won
    An, Suk Kyoon
    Kwon, Jun Soo
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 (09): : 763 - 770
  • [9] Bullying in individuals at ultra-high risk for psychosis
    Fekih-Romdhane, Feten
    Cheour, Majda
    ANNALES MEDICO-PSYCHOLOGIQUES, 2023, 181 (04): : 325 - 329
  • [10] Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis
    De Koning, Mariken B.
    Bloemen, Oswald J. N.
    Van Duin, Esther D. A.
    Booij, Jan
    Abel, Kathryn M.
    De Haan, Lieuwe
    Linszen, Don H.
    Van Amelsvoort, Therese A. M. J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (06) : 553 - 560